18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma

Journal of Gastrointestinal Surgery

Volumn 7, Issue 8, 2003, Pages 953-960

  Sperti, Cosimo ^a   Pasquali, Claudio ^a,c   Chierichetti, Franca ^b   Ferronato, Andrea ^a   Decet, Giandomenico ^a   Pedrazzoli, Sergio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Castelfranco Veneto ^*  (Italy)

^c Ospedale Busonera   (Italy)

Author keywords

Fluorodeoxyglucose; Pancreatic cancer; Positron emission tomography; Prognosis; Standardized uptake value

Indexed keywords

CA 19-9 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGE; AGED; BILE DUCT BYPASS; BLOOD LEVEL; CALCULATION; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC IMAGING; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; STANDARDIZATION;

EID: 0347481287     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.09.002     Document Type: Conference Paper

References (26)

1. Bray F., Sankila R., Ferlay J., Parkin D.M. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 38:2002;99-166.
2. Lim J.E., Chien M.W., Earle C.C. Prognostic factors following curative resection for pancreatic adenocarcinoma. A population-based, linked database analysis of 396 patients. Ann Surg. 237:2003;74-85.
3. Niedergethmann M., Hildebrand R., Wostbrock B., Hartel M., Sturm J.W., Richter A., Post S. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas. 25:2002;122-129.
4. Wittekind C., Compton C., Greene F.L., Sobin L.H. TNM residual tumor classification revisited. Cancer. 94:2002;2511-2519.
5. Sperti C., Pasquali C., Catalini S., Cappellazzo F., Bonadimani B., Behboo R., Pedrazzoli S. CA 19-9 as a prognostic index after resection for pancreatic cancer. J Surg Oncol. 52:1993;137-141.
6. Vogel I., Kalthoff H., Henne-Bruns D., Kremer B. Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology. 2:2002;79-88.
7. Nakata B., Nishimura S., Ishikawa T., Ohira M., Nishino H., Kawabe J., Ochi H., Hirakawa K. Prognostic predictive value of 18-Fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. Int J Oncology. 19:2001;53-58.
8. Delbeke D., Martin W.H. Positron emission tomography imaging in oncology. Radiol Clin N Am. 39:2001;883-917.
9. Hustinx R., Benard F., Alavi A. Whole-body imaging in the management of patients with cancer. Sem Nucl Med. 32:2002;35-46.
10. Rose M., Delbeke D., Beauchamp D., Chapman W.C., Sandler M.P., Sharp K.W., Richards W.O., Write J.K., Frexes M.E., Pinson C.W., Leach S.D. 18-Fluorodeoxyglucose positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg. 229:1998;729-738.
11. Van Heertum R.L., Fawrwaz R.A. The role of nuclear medicine in the evaluation of pancreatic disease. Surg Clin N Am. 82:2001;345-348.
12. Di Chiro G., Delapaz R.L., Brooks R.A., Sokoloff L., Kornblith P.L., Smith B.H., Patronas N.J., Kufta C.V., Kessler R.M., Johnston G.S., Manning R.G., Wolf A.P. Glucose utilization of Cerebral Gliomas measured by (18F) fluorodeoxyglucose and positron emission tomography. Neurology. 32:1982;1323-1329.
13. Patronas N.J., Di Chiro G., Kufta C., Bairamian D., Kornblith P.L., Simon R., Larson S.M. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 62:1985;816-822.
14. Nakata B., Chung Y.S., Nishimura S., Nishihara T., Sakurai Y., Sawada T., Okamura T., Kawabe J., Ochi H., Sowa M. 18-Fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer. 79:1997;695-699.
15. Maisey N.R., Webb A., Flux G.D., Padhani A., Cunningham D.C., Ott R.J., Norman A. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer. 83:2000;287-293.
16. Zimny M., Fass J., Bares R., Cremerius U., Sabri O., Buechin P., Schumpelick V., Buell U. Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scand J Gastroenterology. 35:2000;883-888.
17. Sobin L.H., Wittekind C. UICC: TNM Classification of malignant tumors. Eight edition :1997;John Wiley and sons, Inc, New York.
18. Higashi T., Tamaki N., Honda T., Torizuka T., Kimura T., Inokuma T., Ohshio G., Hosotani R., Imamura M., Konishi J. Expression of glucose transporters in human pancreatic tumours compared with increased FDG accumulation in PET. J Nucl Med. 38:1997;1337-1344.
19. Reske S.N., Grillenberger K.G., Glatting G., Port M., Hildebrandt M., Gansauge F., Beger H.G. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. J Nucl Med. 38:1997;1344-1348.
20. Scheck N., Hall B.L., Finn O.J. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res. 48:1988;6354-6359.
21. Minn H., Joensuu H., Ahonen A., Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumours. Cancer. 61:1988;1776-1781.
22. Higashi K., Clavo A.C., Wahl R.L. Does FDG uptake measure proliferative activity of human cancer cells? In vivo comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med. 34:1993;414-419.
23. Sperti C., Pasquali C., Piccoli A., Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg. 83:1996;625-631.
24. Benassai G., Mastrorilli M., Quarto G., Coppiello A., Giani U., Forestieri P., Mazzeo F. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol. 73:2000;212-218.
25. Townsend D.W., Beyer T. A combined PET/CT scanner: the path to true image fusion. Brit J Radiol. 75:2002;S24-S30.
26. Hany T.F., Steinert H.C., Goerres G.W., Buck A., von Schulthess G.K. PET diagnostic accuracy: improvement with inline PET-CT system: initial results. Radiology. 225:2002;575-581.